The oral wellness system features distinct morning and nighttime formulas with ingredients like magnesium and L-theanine. Should it be incorporated into the bedtime routine?

A post hoc analysis of the SELECT trial suggests that semaglutide 2.4 mg is associated with a significantly lower incidence of obstructive sleep apnea in adults with overweight or obesity and established cardiovascular d...

Recent physician payment debate in Congress Over the past several years, physician payment has remained one of the most urgent health policy issues before Congress. For sleep physicians, Medicare payment policy directly...

Many adults struggle to get a good night’s sleep. In fact, a recent data analysis by the Centers for Disease Control and Prevention shows that nearly 13% of U.S. adults use a sleep aid most days or every day in the past...

'These findings help us better understand the biological mechanisms linking obstructive sleep apnea to metabolic disease.'

Tirzepatide injection becomes the first medication authorized in Canada for moderate to severe OSA, demonstrating significant reductions in breathing disruptions in clinical trials.

A personal story explores why women with cardiovascular disease deserve earlier conversations about sleep-disordered breathing.

Eli Lilly and Company has completed its acquisition of Centessa Pharmaceuticals, securing a portfolio of clinical-stage orexin receptor 2 agonists. This strategic move aims to accelerate the development of new treatments...

Survey findings suggest fatigue remains widespread and debilitating across narcolepsy and idiopathic hypersomnia, even among patients taking medications.

Phase 3 TRIUMPH-1 trial data show retatrutide reduced the AHI by up to 36.1 events per hour alongside substantial weight loss.